0 false false false false false false false false false false true false false false false false false No description of principal activity 2023-04-01 Sage Accounts Production Advanced 2023 - FRS102_2023 1,000 1,000 1,000 xbrli:pure xbrli:shares iso4217:GBP 04017529 2023-04-01 2024-03-31 04017529 2024-03-31 04017529 2023-03-31 04017529 2022-04-01 2023-03-31 04017529 2023-03-31 04017529 2022-03-31 04017529 bus:Director1 2023-04-01 2024-03-31 04017529 core:ShareCapital 2024-03-31 04017529 core:ShareCapital 2023-03-31 04017529 core:RetainedEarningsAccumulatedLosses 2024-03-31 04017529 core:RetainedEarningsAccumulatedLosses 2023-03-31 04017529 core:LandBuildings core:ShortLeaseholdAssets 2024-03-31 04017529 core:LandBuildings core:ShortLeaseholdAssets 2023-03-31 04017529 bus:SmallEntities 2023-04-01 2024-03-31 04017529 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 04017529 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 04017529 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 04017529 bus:FullAccounts 2023-04-01 2024-03-31
COMPANY REGISTRATION NUMBER: 04017529
Pampard Pharmacy Limited
Filleted Unaudited Financial Statements
31 March 2024
Pampard Pharmacy Limited
Statement of Financial Position
31 March 2024
2024
2023
Note
£
£
Fixed assets
Tangible assets
4
1,000
1,000
-------
-------
Total assets less current liabilities
1,000
1,000
-------
-------
Capital and reserves
Called up share capital
100
100
Profit and loss account
900
900
-------
-------
Shareholders funds
1,000
1,000
-------
-------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 20 March 2025 , and are signed on behalf of the board by:
Mr A M Mansour
Director
Company registration number: 04017529
Pampard Pharmacy Limited
Notes to the Financial Statements
Year ended 31 March 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 9 Lydford Road, London, NW2 5QY.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Tangible assets
Tangible assets are initially recorded at cost. No depreciation has been charged.
4. Tangible assets
Short leasehold property
£
Cost
At 1 April 2023 and 31 March 2024
1,000
-------
Depreciation
At 1 April 2023 and 31 March 2024
-------
Carrying amount
At 31 March 2024
1,000
-------
At 31 March 2023
1,000
-------
5. Controlling party
The company was controlled by Canary Trading Company Limited during the year ended 31 May 2020, a company incorporated in the United Kingdom,. .